Le Lézard
Classified in: Health
Subject: SVY

Remote Patient Monitoring Device Market Report 2020 - Assessment by Product, Type, End-user and Region (2018-2027)

DUBLIN, June 3, 2020 /PRNewswire/ -- The "Global Remote Patient Monitoring Device Market Outlook 2027" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The worldwide market of remote patient monitoring is anticipated to achieve a CAGR of 14.94% during the forecast period, i.e. 2020-2027.

Factors such as rising incidences of cardiovascular disorders amongst individuals, coupled with factors such as favorable government policies, advancement in healthcare facilities and the changes observed in the adoption of remote patient monitoring services are some of the factors anticipated to promote the growth of the global remote patient monitoring market. The market is also thriving owing to the opportunities that are derived from increasing R&D investments for the development of healthcare infrastructure and the strategic collaborations and partnerships amongst manufacturers in the healthcare industry.

Moreover, growing concern for the increasing number of chronic diseases worldwide coupled with increasing number of diabetic patients, increasing funding by the governments of nations for R&D and the advancements in the quality of healthcare services are some of the factors anticipated to drive the growth of the global remote patient monitoring market.

The global remote patient monitoring market consists of various segments that are segmented by product, type, end user and by region. The type segment is further sub-divided into wireless and wired, out of which, the wireless segment is anticipated to hold the largest market share and grow with a CAGR of 15.31% during the forecast period. Additionally, the segment is also anticipated to attain an absolute $ opportunity of USD 5,931.85 million during the forecast period. On the other hand, the hospital segment, which is a sub-segment of the end-user segment, is anticipated to hold the largest market share and attain a value of USD 883.62 million by the end of 2027 by growing at a CAGR of 14.63% during the forecast period.

Based on region, the global remote patient monitoring market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in Asia Pacific, which had accounted for 20.97% share in the year 2018, is estimated to grow with a CAGR of 16.06% over the forecast period owing to the rising geriatric population and increasing demand for advanced monitoring solutions.

Some of the affluent industry leaders in the global remote patient monitoring market are BioTelemetry, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Resideo Technologies, Inc., Abbott, Boston Scientific Corporation, General Electric Company (GE Healthcare), Medtronic, F. Hoffmann-La Roche Ltd and ZOLL Medical Corporation.

Key Topics Covered

1. Introduction

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary

5. Key Market Opportunities

6. Regulatory Landscape

7. Analysis of Market Dynamics
7.1. Growth Drivers
7.2. Restraints
7.3. Key Trends

8. Epidemiology Analysis
8.1. Diabetes
8.2. Cardiovascular Disorders
8.3. Respiratory Disorders
8.4. Cancer

9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10. Global Remote Patient Monitoring Market Outlook
10.1. Market Size and Forecast, 2018-2027
10.1.1. By Value (USD Million)
10.2. Global Remote Patient Monitoring Market Segmentation, 2018-2027
10.2.1. By Product
10.2.2. By Type
10.2.3. By End-user
10.2.4. By Region

11. Competitive Structure
11.1. Detailed Overview
11.2. Assessment of Key Product Offerings
11.3. Analysis of Growth Strategies
11.4. Key Collaborations and Joint Ventures
11.5. Key Mergers and Acquisitions
11.6. Recent News and Developments
11.7. Key Clients and Partners
11.8. Exhaustive Analysis on Key Financial Indicators
11.9. Company Profiles of Global Remote Patient Monitoring Market
11.9.1. Biotelemetry Inc.
11.9.2. Mindray
11.9.3. Resideo
11.9.4. Abbott
11.9.5. Boston Scientific
11.9.6. GE Healthcare
11.9.7. Medtronic
11.9.8. Roche
11.9.9. Zoll Medical

12. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/ngxjau

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

These press releases may also interest you

at 21:22
Expesicor, a privately held biopharma company focused on preventing, treating, and curing neurological disorders, is excited to announce its collaboration with Massachusetts General Hospital (MGH) in Boston. Expesicor and MGH are working to develop a...

at 21:00
Profound Medical Corp. ("Profound" or the "Company") is pleased to announce the pricing of an underwritten public offering (the "Offering") of 2,758,621 common shares of the Company (the "Common Shares"), at a price of US$14.50 per Common Share (the...

at 20:05
Bio-Rad Laboratories, Inc. , a global leader of life science research and clinical diagnostic products, will report financial results for the second quarter 2020 on Thursday, July 30, 2020, following the close of the market. The company will discuss...

at 19:32
On behalf of the American BioDefense Institute, we commend Rep. Paul Gosar of Arizona on proposing an amendment to the H.R.6395 - William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021. We submit this statement for the...

at 19:01
In lieu of an in-person update to the media, Dr. Howard Njoo, Canada's Deputy Chief Public Health Officer, issued the following statement on behalf of Dr. Theresa Tam, Canada's Chief Public Health Officer. "There have been 108,486 cases of COVID-19...

at 18:57
Neptune Wellness Solutions Inc. ("NEPT" or the "Company") , a diversified and fully integrated health and wellness company focused on natural, plant-based, sustainable and purpose-driven lifestyle brands, today announced it has closed its...

News published on 3 june 2020 at 17:00 and distributed by: